about
Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case studyImpact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaborationForging Collaborative Relationships in Brazil: From AIDS to ZIKVChloroquine inhibits Zika Virus infection in different cellular modelsEvidence for Transmission of Zika Virus by Platelet TransfusionCongenital Brain Abnormalities and Zika Virus: What the Radiologist Can Expect to See Prenatally and PostnatallyCongenital Zika Virus InfectionDevelopment of a rapid phenotypic test for HCV protease inhibitors with potential use in clinical decisionsPregnant women carrying microcephaly foetuses and Zika virus contain potentially pathogenic microbes and parasites in their amniotic fluidChloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell ModelsDifferential drug resistance acquisition in HIV-1 of subtypes B and CDifferential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and CEvolution of primary HIV drug resistance in a subtype C dominated epidemic in MozambiqueHIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particlesGeographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysisTrends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, MozambiqueCorrection: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-AnalysisSingle Nucleotide Polymorphisms in Cellular Drug Transporters Are Associated with Intolerance to Antiretroviral Therapy in Brazilian HIV-1 Positive IndividualsImmune activation in amniotic fluid from Zika virus-associated microcephalyZika virus disrupts molecular fingerprinting of human neurospheresZika Virus Causing Encephalomyelitis Associated With ImmunoactivationDengue infection in the nervous system: lessons learned for Zika and ChikungunyaThe spectrum of neuropathological changes associated with congenital Zika virus infectionZika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A ReviewDifferent epidemic potentials of the HIV-1B and C subtypes.Frequency of human immunodeficiency virus type-2 in hiv infected patients in Maputo City, MozambiqueGenetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo City, MozambiquePrevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naïve human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil.Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.Synthetic 1,4-pyran naphthoquinones are potent inhibitors of dengue virus replication.Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR.Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil.Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantificationIn vitro hypersusceptibility of human immunodeficiency virus type 1 subtype C protease to lopinavir.Natural transmission of feline immunodeficiency virus from infected queen to kittenIn vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genesGenetic diversity and naturally polymorphisms in HIV type 1 integrase isolates from Maputo, Mozambique: implications for integrase inhibitorsField expansion of DNA polymerase chain reaction for early infant diagnosis of HIV-1: The Ethiopian experience.Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study
P50
Q24311332-3390E60B-D826-4E6D-AC76-05EE897C0F8DQ24792432-BCC7EC10-C275-415C-844D-44B44EF179D7Q25178249-B3A44999-0216-4ED8-BE41-6F914DF07EBDQ25707168-135478B4-A149-45E1-B7D5-C33F0A6C51D7Q26316619-0C8739C8-9D8E-4C5C-9333-0E34E3633120Q26689474-462680DB-5B13-4314-8EAA-9F626EB80FB5Q27108235-B6E1D9DB-C724-44B3-8AA8-D84B26FED95EQ27468990-7111D8BC-67EB-442A-8B0C-8CAE40B8CBF1Q28222194-9DA3F7A9-5D71-43AC-B80D-F51A6E77C5E1Q28353981-1DCBA2E6-5863-4093-A13C-16E0E9C36C33Q28469273-E0F2296F-C3E2-4CC4-B600-4C056216D403Q28484213-FBB7C2AC-8311-43FC-B77B-D1270E439FBCQ28535000-1214F4DA-EC3E-41AB-9429-B48C956DA920Q28538038-D86B2786-C269-443D-9C53-CA2A0E614215Q28545866-DE6C1DE9-1A6F-4E4D-A5E1-677A053B4A12Q28546341-C6678688-3682-4E06-BE40-EA46A7BCF175Q28547717-93B301C1-BECB-498A-969F-20E5D695C4DEQ28554250-BB2F4A23-4FB3-4917-917D-5D03E2598BCEQ28577836-2D200B88-BDD6-4ED9-9AB1-AC8C52A47EE4Q28582619-6E0B9A31-ACEE-47BD-8EFB-1539621DAB0FQ28595389-5DB29878-111B-421A-AD40-8760C1AB1082Q28837087-F7946C12-A051-4F0B-8161-EBA1CCA9C113Q29364973-7EF9DBEB-A40D-47FD-B2FA-FB52AC31E70EQ29647477-D3C16CF6-7AF3-4B95-BE13-AE04F27EBA35Q30011040-888FC69F-82ED-48D8-8899-E8D821903243Q30406079-3D8F4FF2-267A-461F-9B7F-1C537BF2FFEDQ33713862-BFDF83EB-6C8A-4D15-AB62-B5329A25DDA2Q34112169-00467287-6AE2-4E04-85B0-FE0622184D39Q34352000-AAD1E6E2-1163-4F1B-9054-1F400B35AE45Q34989641-8400328A-64B1-4187-83E8-336E08B71D2BQ35077611-E688AF13-52DD-43F7-AD6E-F9A7F629795FQ35168379-C14D3A2B-CA1B-4EF8-9930-9B67236BBFF6Q35551677-865AD063-CF8F-4C99-BFC0-865A41E49E11Q35636068-89A2F5DE-25FB-4AD7-8CAF-10AFC99BA795Q35685268-7FE916F1-30A2-4879-A5F4-418C58B6CDEAQ36226416-05DF8507-606C-41BA-A247-5EDE5D82C5B0Q36376217-B3520222-FD52-4089-A036-4B352B2113E2Q36419510-5E83F73F-708B-4FD2-BF9E-5B1AA9C76D30Q36542755-07C085C7-C295-436C-8927-7C0B6A92610DQ36689877-BA73B4FD-D8C0-4830-8AD0-A9846336AA0C
P50
description
epidemiologist
@en
name
Amilcar Tanuri
@ast
Amilcar Tanuri
@en
Amilcar Tanuri
@es
Amilcar Tanuri
@nl
type
label
Amilcar Tanuri
@ast
Amilcar Tanuri
@en
Amilcar Tanuri
@es
Amilcar Tanuri
@nl
altLabel
A Tanuri
@en
A. Tanuri
@en
prefLabel
Amilcar Tanuri
@ast
Amilcar Tanuri
@en
Amilcar Tanuri
@es
Amilcar Tanuri
@nl
P106
P21
P31
P569
1958-09-04T00:00:00Z